These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 26609648)

  • 1. Treatment effectiveness in patients with schizophrenia as measured by the ASSESS battery - first longitudinal data.
    Ladea M; Barbu CM; Juckel G
    Psychiatr Danub; 2015 Dec; 27(4):364-70. PubMed ID: 26609648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychometric evaluation of the Medication Satisfaction Questionnaire (MSQ) to assess satisfaction with antipsychotic medication among schizophrenia patients.
    Vernon MK; Revicki DA; Awad AG; Dirani R; Panish J; Canuso CM; Grinspan A; Mannix S; Kalali AH
    Schizophr Res; 2010 May; 118(1-3):271-8. PubMed ID: 20172695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Remission as perceived by people with schizophrenia, family members and psychiatrists.
    Karow A; Naber D; Lambert M; Moritz S;
    Eur Psychiatry; 2012 Aug; 27(6):426-31. PubMed ID: 21571506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of Antipsychotic Drugs for 24-Month Maintenance Treatment in First-Episode Schizophrenia: Evidence From a Community-Based "Real-World" Study.
    Zhang C; Chen MJ; Wu GJ; Wang ZW; Rao SZ; Zhang Y; Yi ZH; Yang WM; Gao KM; Song LS
    J Clin Psychiatry; 2016 Nov; 77(11):e1460-e1466. PubMed ID: 28076667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Negative symptoms and psychosocial functioning in schizophrenia: neglected but important targets for treatment.
    Hunter R; Barry S
    Eur Psychiatry; 2012 Aug; 27(6):432-6. PubMed ID: 21602034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measuring social functioning with the personal and social performance scale in patients with acute symptoms of schizophrenia: interpretation of results of a pooled analysis of three Phase III trials of paliperidone extended-release tablets.
    Patrick DL; Burns T; Morosini P; Gagnon DD; Rothman M; Adriaenssen I
    Clin Ther; 2010 Feb; 32(2):275-92. PubMed ID: 20206786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subjective assessments of the quality of life, well-being and self-efficacy in patients with schizophrenia.
    Chino B; Nemoto T; Fujii C; Mizuno M
    Psychiatry Clin Neurosci; 2009 Aug; 63(4):521-8. PubMed ID: 19531107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel rating scales for schizophrenia - Targeted Inventory on Problems in Schizophrenia (TIP-Sz) and Functional Assessment for Comprehensive Treatment of Schizophrenia (FACT-Sz).
    Suzuki T; Uchida H; Nomura K; Takeuchi H; Nakajima S; Tanabe A; Yagi G; Watanabe K; Kashima H
    Schizophr Res; 2008 Dec; 106(2-3):328-36. PubMed ID: 18804960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Symptoms, cognitive functioning, and adaptive skills in geriatric patients with lifelong schizophrenia: a comparison across treatment sites.
    Harvey PD; Howanitz E; Parrella M; White L; Davidson M; Mohs RC; Hoblyn J; Davis KL
    Am J Psychiatry; 1998 Aug; 155(8):1080-6. PubMed ID: 9699697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential cognitive performances between schizophrenic responders and non-responders to antipsychotics: correlation with course of the illness, psychopathology, attitude to the treatment and antipsychotics doses.
    de Bartolomeis A; Balletta R; Giordano S; Buonaguro EF; Latte G; Iasevoli F
    Psychiatry Res; 2013 Dec; 210(2):387-95. PubMed ID: 23910239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Evolution of the social autonomy scale (EAS) in schizophrenic patients depending on their management].
    Leguay D; Rouillon F; Azorin JM; Gasquet I; Loze JY; Arnaud R; Dillenschneider A
    Encephale; 2010 Oct; 36(5):397-407. PubMed ID: 21035630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation between the Personal and Social Performance scale (PSP) and the Positive and Negative Syndrome Scale (PANSS) in a Greek sample of patients with schizophrenia.
    Jelastopulu E; Giourou E; Merekoulias G; Mestousi A; Moratis E; Alexopoulos EC
    BMC Psychiatry; 2014 Jul; 14():197. PubMed ID: 25005616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Understanding the course of persistent symptoms in schizophrenia: Longitudinal findings from the pattern study.
    Haro JM; Altamura C; Corral R; Elkis H; Evans J; Krebs MO; Zink M; Malla A; Méndez JI; Bernasconi C; Lalonde J; Nordstroem AL
    Psychiatry Res; 2018 Sep; 267():56-62. PubMed ID: 29883861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is it true remission? A study of remitted patients affected by schizophrenia and schizoaffective disorders.
    Pinna F; Deriu L; Lepori T; Maccioni R; Milia P; Sarritzu E; Tusconi M; Carpiniello B;
    Psychiatry Res; 2013 Dec; 210(3):739-44. PubMed ID: 24007858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment resistant schizophrenia is associated with the worst community functioning among severely-ill highly-disabling psychiatric conditions and is the most relevant predictor of poorer achievements in functional milestones.
    Iasevoli F; Giordano S; Balletta R; Latte G; Formato MV; Prinzivalli E; De Berardis D; Tomasetti C; de Bartolomeis A
    Prog Neuropsychopharmacol Biol Psychiatry; 2016 Feb; 65():34-48. PubMed ID: 26320028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Satisfaction of immediate or delayed switch to paliperidone palmitate in patients unsatisfied with current oral atypical antipsychotics.
    Kwon JS; Kim SN; Han J; Lee SI; Chang JS; Choi JS; Lee HJ; Cho SJ; Jun TY; Lee SH; Han C; Lee KU; Lee KK; Lee E
    Int Clin Psychopharmacol; 2015 Nov; 30(6):320-8. PubMed ID: 26196188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Symptomatic remission and cognitive impairment in first-episode schizophrenia: a prospective 3-year follow-up study.
    Chang WC; Ming Hui CL; Yan Wong GH; Wa Chan SK; Ming Lee EH; Hai Chen EY
    J Clin Psychiatry; 2013 Nov; 74(11):e1046-53. PubMed ID: 24330905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. No gender differences in social outcome in patients suffering from schizophrenia.
    Galderisi S; Bucci P; Üçok A; Peuskens J
    Eur Psychiatry; 2012 Aug; 27(6):406-8. PubMed ID: 21616645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The illness and everyday living: close interplay of psychopathological syndromes and psychosocial functioning in chronic schizophrenia.
    Schaub D; Brüne M; Jaspen E; Pajonk FG; Bierhoff HW; Juckel G
    Eur Arch Psychiatry Clin Neurosci; 2011 Mar; 261(2):85-93. PubMed ID: 20652295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.